Select Page

American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 Update
Samson S, Vellanki P, Blonde L, Christofides E, Umpierrez G et al
On line 5 mayo 2023, Endocrine Practice

Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetes
Heller S, Battelino, Bailey T, Pieber T, Pieber T et al

Management of adults with diabetes on dialysis: Summary of recommendations of the Joint British Diabetes Societies guidelines 2022
Frankel A, Whaba M,  Ashworth V, Bedi R, Berrington et al

Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL Around Spontaneous Exercise Sessions in Adults with Type 1 Diabetes: A Randomized Cross-Over Trial (ULTRAFLEXI-1 Study)
Moser O,  Muller F, Aberer F, Aziz F; koizar H et al
Diabetes Technol Ther. 2023 Mar;25(3):161-168.

Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial.
Feig D, Sanchez J, Murphy K, Astalos E, Zinman B, Sinmons D  et al.
Lancet Diabetes Endocrinol. 2023 Mar;11(3):191-202.